- Home
- PEBK vs IMRX Comparison
PEBK vs IMRX Comparison
Compare PEBK & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEBK
- IMRX
- Stock Information
- Founded
- PEBK 1912
- IMRX 2008
- Country
- PEBK United States
- IMRX United States
- Employees
- PEBK N/A
- IMRX N/A
- Industry
- PEBK Major Banks
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- PEBK Finance
- IMRX Health Care
- Exchange
- PEBK Nasdaq
- IMRX Nasdaq
- Market Cap
- PEBK 145.9M
- IMRX 145.7M
- IPO Year
- PEBK N/A
- IMRX 2021
- Fundamental
- Price
- PEBK $29.81
- IMRX $4.17
- Analyst Decision
- PEBK
- IMRX Strong Buy
- Analyst Count
- PEBK 0
- IMRX 4
- Target Price
- PEBK N/A
- IMRX $13.25
- AVG Volume (30 Days)
- PEBK 12.3K
- IMRX 3.2M
- Earning Date
- PEBK 07-21-2025
- IMRX 08-05-2025
- Dividend Yield
- PEBK 3.21%
- IMRX N/A
- EPS Growth
- PEBK 4.04
- IMRX N/A
- EPS
- PEBK 3.05
- IMRX N/A
- Revenue
- PEBK $83,033,000.00
- IMRX N/A
- Revenue This Year
- PEBK N/A
- IMRX N/A
- Revenue Next Year
- PEBK N/A
- IMRX N/A
- P/E Ratio
- PEBK $9.81
- IMRX N/A
- Revenue Growth
- PEBK 7.01
- IMRX N/A
- 52 Week Low
- PEBK $23.74
- IMRX $1.00
- 52 Week High
- PEBK $33.31
- IMRX $4.60
- Technical
- Relative Strength Index (RSI)
- PEBK 55.71
- IMRX 68.17
- Support Level
- PEBK $29.25
- IMRX $3.31
- Resistance Level
- PEBK $30.08
- IMRX $4.60
- Average True Range (ATR)
- PEBK 1.07
- IMRX 0.45
- MACD
- PEBK 0.07
- IMRX 0.07
- Stochastic Oscillator
- PEBK 56.33
- IMRX 79.72
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.